Skip to main content
. Author manuscript; available in PMC: 2025 Aug 25.
Published in final edited form as: Clin Cancer Res. 2025 Sep 15;31(18):3922–3931. doi: 10.1158/1078-0432.CCR-25-1071

Figure 2: Molecular features of NUT carcinoma.

Figure 2:

(A) Distribution of TMB in cases that had DNA NGS testing (B) Distribution of PD-L1 expression in cases that had DNA NGS testing (C) Oncoprint of the most common co-occurring gene mutations with clinical interest from DNA NGS tests (D) Prevalence of co-occurring mutations in patients with NC classified by epigenetic, cell cycle, and DNA repair functions (E) Distribution of the exon variants for NUTM1 and the fusion partner genes in the exon fusion cohort (F) Distribution of NUT exon fusion variants in the exon fusion cohort